IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $614,000 | +8.3% | 20,500 | 0.0% | 0.01% | +30.0% |
| Q4 2019 | $567,000 | +52.0% | 20,500 | 0.0% | 0.01% | +42.9% |
| Q3 2019 | $373,000 | -25.8% | 20,500 | 0.0% | 0.01% | -30.0% |
| Q2 2019 | $503,000 | +157.9% | 20,500 | 0.0% | 0.01% | +150.0% |
| Q1 2019 | $195,000 | +7.7% | 20,500 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $181,000 | +24.8% | 20,500 | +58.9% | 0.01% | +150.0% |
| Q3 2018 | $145,000 | -12.1% | 12,900 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $165,000 | -5.2% | 12,900 | +25.2% | 0.00% | 0.0% |
| Q1 2018 | $174,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |